Over-the-counter Narcan is hitting shelves in September
Biomedical company Emergent BioSolutions announced Wednesday its opioid overdose-reversing naloxone product is expected to hit the shelves starting in September.
Stay updated with breaking news from Divya Venkat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biomedical company Emergent BioSolutions announced Wednesday its opioid overdose-reversing naloxone product is expected to hit the shelves starting in September.
Emergent’s name-brand Narcan was FDA-approved in March, and was the first-ever naloxone product to be approved for use without a prescription in the U.S.
The move will allow law enforcement to impose additional penalties on those charged with manufacturing or distributing xylazine.
Pittsburgh, PA (PRWEB) December 14, 2021 -- Allegheny Health Network (AHN) announced today that its Center for Inclusion Health has launched an innovative